Pages that link to "Q28252695"
Jump to navigation
Jump to search
The following pages link to mTOR signaling in tumorigenesis (Q28252695):
Displaying 50 items.
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials (Q26751155) (← links)
- Evolutionary Limitation and Opportunities for Developing tRNA Synthetase Inhibitors with 5-Binding-Mode Classification (Q26775728) (← links)
- Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma (Q28067482) (← links)
- Regulation of Ketone Body Metabolism and the Role of PPARα (Q28073224) (← links)
- FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance (Q28077347) (← links)
- mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging (Q28081442) (← links)
- HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss. (Q33626569) (← links)
- Insulin Increases Sestrin 2 Content by Reducing Its Degradation through the PI 3 K/mTOR Signaling Pathway (Q35156158) (← links)
- SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway (Q35761691) (← links)
- α-Mangostin, a Natural Agent, Enhances the Response of NRAS Mutant Melanoma to Retinoic Acid (Q35996844) (← links)
- Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression (Q36544967) (← links)
- N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells (Q36651651) (← links)
- The Transcription Factor p8 Regulates Autophagy in Response to Palmitic Acid Stress via a Mammalian Target of Rapamycin (mTOR)-independent Signaling Pathway (Q36744503) (← links)
- Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth (Q36916277) (← links)
- Genetics of tuberous sclerosis complex: implications for clinical practice (Q37536133) (← links)
- Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures (Q37597272) (← links)
- mTOR function and therapeutic targeting in breast cancer (Q37743486) (← links)
- Pleurotus nebrodensis polysaccharide(PN50G) evokes A549 cell apoptosis by the ROS/AMPK/PI3K/AKT/mTOR pathway to suppress tumor growth (Q38790829) (← links)
- Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu (Q38935156) (← links)
- Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors (Q40089006) (← links)
- Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses. (Q40089027) (← links)
- Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer. (Q40472184) (← links)
- Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets (Q41021890) (← links)
- Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling (Q41609951) (← links)
- Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models (Q41781449) (← links)
- mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer (Q42359443) (← links)
- Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. (Q42649115) (← links)
- Inducible CRISPR genome-editing tool: classifications and future trends (Q46302920) (← links)
- Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis (Q47143132) (← links)
- Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets (Q47393972) (← links)
- Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock (Q47445843) (← links)
- GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation. (Q47588788) (← links)
- Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors (Q49035818) (← links)
- Meta-analysis of the prognostic value of p-4EBP1 in human malignancies (Q49515435) (← links)
- New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy. (Q52677298) (← links)
- Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor-positive Breast Cancer. (Q52730266) (← links)
- Genetic Variants Within MTORC1 Genes Predict Gastric Cancer Prognosis in Chinese Populations. (Q55061367) (← links)
- Hypoxic Signalling in Tumour Stroma. (Q55284922) (← links)
- Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (Q57108041) (← links)
- Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism (Q57295882) (← links)
- URI knockdown induces autophagic flux in gastric cancer cells (Q58790027) (← links)
- An Integrated Score and Nomogram Combining Clinical and Immunohistochemistry Factors to Predict High ISUP Grade Clear Cell Renal Cell Carcinoma (Q60949867) (← links)
- A microRNA signature for the differential diagnosis of salivary gland tumors (Q61809649) (← links)
- Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells (Q64233753) (← links)
- Longitudinal study of leukocyte DNA methylation and biomarkers for cancer risk in older adults (Q64288374) (← links)
- High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer (Q89484932) (← links)
- The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease (Q89544479) (← links)
- Circular METRN RNA hsa_circ_0037251 Promotes Glioma Progression by Sponging miR-1229-3p and Regulating mTOR Expression (Q92239485) (← links)
- Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway (Q92358232) (← links)